Healthcare Global Enterprises Share Price

Healthcare Global Enterprises Share Price

  • 630.501.11 (0.18%)
  • Closed
  • As On: 12 Jun, 2026, 03:53 PM IST
Loading...
Open630.00
High639.20
Low625.00
Prev Close629.40
Volume1,40,507
VWAP(₹)632.06

Key Metrics

PE Ratio(x)683.13
EPS - TTM(₹)0.92
MCap(₹ Cr.)9,413.50
MCap Rank16
PB Ratio(x)6.73
Div Yield(%)-
Face Value(₹)10.00
52W High(₹)788.39
52W Low(₹)513.30
MCap/Sales3.08
Beta(1 Month)0.73
BV/Share(₹)94.45

Healthcare Global share price insights

  • Employee & Interest Expense

    Company has spent 6.94% of its operating revenues towards interest expenses and 14.87% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • Healthcare Global Share Price Update

    Healthcare Global Enterprises Ltd. share price moved up by 0.18% from its previous close of Rs 629.40. Healthcare Global Enterprises Ltd. stock last traded price is 630.50

    Share PriceValue
    Today/Current/Last630.50
    Previous Day629.40

Found Insights useful?

Healthcare Global Share Price Returns

1 Day0.18%
1 Month3.98%
3 Months12.53%
1 Year15.69%
3 Years100.19%
5 Years219.0%

Healthcare Global Share Recommendations

Mean recosCurrent
STRONG BUY

6 Analysts

Strong
Sell
SellHoldBuyStrong
Buy
Analyst Trends
RatingsCurrent1W Ago1M Ago3M Ago
Strong Buy3332
Buy3323
Hold----
Sell----
Strong Sell----
# Analysts6655
Recent Recos
  • Target₹575
  • OrganizationAxis Securities
  • BUY
  • Target₹575
  • OrganizationAxis Securities
  • BUY
  • Target₹410
  • OrganizationICICI Securities
  • ADD

Share Analysis

EARNINGS
FUNDAMENTAL
RELATIVE VALUATION
RISK
PRICE MOMENTUM

Unlock Stock Score, Analyst' Ratings & Recommendations

  • Score on 10-point scale
  • Ratings by analysts
  • Stock performance
JOIN ET PRIME

Financials

  • Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income665.40635.54649.47619.99595.39
    Total Income Growth (%)4.70-2.144.754.135.71
    Total Expenses621.97596.78586.34563.28537.51
    Total Expenses Growth (%)4.221.784.094.792.05
    EBIT43.4338.7663.1356.7157.88
    EBIT Growth (%)12.05-38.6011.32-2.0258.58
    Profit after Tax (PAT)2.17-9.4316.294.757.36
    PAT Growth (%)--157.89242.95-35.465.44
    EBIT Margin (%)6.536.109.729.159.72
    Net Profit Margin (%)0.33-1.482.510.771.24
    Basic EPS (₹)0.15-0.681.160.340.53
    Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025
    Total Income365.13345.15349.66335.03333.84
    Total Income Growth (%)5.79-1.294.370.365.05
    Total Expenses353.89325.81313.70305.49294.54
    Total Expenses Growth (%)8.623.862.693.72-11.53
    EBIT11.2419.3435.9629.5439.30
    EBIT Growth (%)-41.88-46.2221.73-24.83-
    Profit after Tax (PAT)1.53-1.1810.783.4510.15
    PAT Growth (%)--110.95212.46-66.01-
    EBIT Margin (%)3.085.6010.288.8211.77
    Net Profit Margin (%)0.42-0.343.081.033.04
    Basic EPS (₹)0.11-0.080.770.250.73
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue2,570.402,257.661,929.061,707.631,410.45
    Total Revenue Growth (%)13.8517.0312.9721.0736.89
    Total Expenses2,500.362,201.471,865.631,662.731,415.86
    Total Expenses Growth (%)13.5818.0012.2017.4421.51
    Profit after Tax (PAT)13.7644.4148.1629.3553.73
    PAT Growth (%)-69.02-7.7864.08-45.38-
    Operating Profit Margin (%)9.689.489.028.776.60
    Net Profit Margin (%)0.541.992.521.733.84
    Basic EPS (₹)0.973.193.462.114.14
    FY 2026FY 2025FY 2024FY 2023FY 2022
    Total Revenue1,394.971,315.101,116.171,016.39862.25
    Total Revenue Growth (%)6.0717.829.8217.8836.24
    Total Expenses1,329.971,260.701,045.21955.77834.12
    Total Expenses Growth (%)5.4920.629.3614.5821.80
    Profit after Tax (PAT)14.583.5333.9640.1938.25
    PAT Growth (%)313.38-89.61-15.515.07-
    Operating Profit Margin (%)11.0910.8110.8110.158.32
    Net Profit Margin (%)1.060.273.083.994.48
    Basic EPS (₹)1.030.252.442.892.95

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Employee & Interest Expense

      Company has spent 6.94% of its operating revenues towards interest expenses and 14.87% towards employee cost in the year ending Mar 31, 2026. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets3,922.543,543.242,707.502,316.022,219.52
    Total Assets Growth (%)10.7130.8716.904.359.03
    Total Liabilities2,512.332,553.191,842.381,446.601,335.81
    Total Liabilities Growth (%)-1.6038.5827.368.291.07
    Total Equity1,410.21990.05865.12869.42883.71
    Total Equity Growth (%)42.4414.44-0.49-1.6223.77
    Current Ratio (x)1.120.810.911.021.07
    Total Debt to Equity (x)0.681.090.810.460.47
    Contingent Liabilities0.00290.44452.63340.9087.24
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Total Assets2,917.342,603.802,187.891,729.711,643.62
    Total Assets Growth (%)12.0419.0126.495.244.39
    Total Liabilities1,312.561,412.48999.31584.59545.93
    Total Liabilities Growth (%)-7.0741.3570.947.08-16.10
    Total Equity1,604.781,191.321,188.591,145.121,097.69
    Total Equity Growth (%)34.710.233.804.3218.83
    Current Ratio (x)1.661.031.371.691.66
    Total Debt to Equity (x)0.350.550.330.110.10
    Contingent Liabilities0.00554.76391.71327.23247.15

    All figures in Rs Cr, unless mentioned otherwise

  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities347.10317.11284.58251.59220.12
    Net Cash used in Investing Activities-177.47-487.75-225.73-133.03124.59
    Net Cash flow from Financing Activities240.67-42.44-64.02-140.07-154.89
    Net Cash Flow410.30-213.08-5.16-21.51189.83
    Closing Cash & Cash Equivalent363.23-47.06166.02171.18192.69
    Closing Cash & Cash Equivalent Growth (%)-871.80-128.35-3.02-11.166,625.65
    Total Debt/ CFO (x)2.623.162.361.591.85
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Net Cash flow from Operating Activities160.19145.95194.71130.40124.40
    Net Cash used in Investing Activities-75.81-347.32-249.20-137.7048.65
    Net Cash flow from Financing Activities336.21-41.55105.36-41.71-41.04
    Net Cash Flow420.59-242.9250.87-49.02132.00
    Closing Cash & Cash Equivalent298.84-121.75121.1870.31119.33
    Closing Cash & Cash Equivalent Growth (%)-345.46-200.4772.36-41.08-1,041.44
    Total Debt/ CFO (x)3.544.462.030.930.86

    All figures in Rs Cr, unless mentioned otherwise

    Insights
    • Decrease in Cash from Investing

      Company has used Rs 177.47 cr for investing activities which is an YoY decrease of 63.61%. (Source: Consolidated Financials)
  • AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)1.034.815.833.416.17
    Return on Capital Employed (%)8.488.448.768.505.27
    Return on Assets (%)0.351.251.771.262.42
    Interest Coverage Ratio (x)2.782.733.193.012.56
    Asset Turnover Ratio (x)0.680.710.760.750.46
    Price to Earnings (x)588.24169.4998.04125.0069.93
    Price to Book (x)5.888.135.704.254.31
    EV/EBITDA (x)16.8719.4814.7712.4015.86
    EBITDA Margin (%)19.2818.9818.1618.4317.93
    AnnualFY 2026FY 2025FY 2024FY 2023FY 2022
    Return on Equity (%)0.900.292.853.503.48
    Return on Capital Employed (%)6.346.996.556.764.96
    Return on Assets (%)0.490.131.552.322.32
    Interest Coverage Ratio (x)3.142.974.444.613.72
    Asset Turnover Ratio (x)0.490.530.560.600.53
    Price to Earnings (x)555.562,500.00138.8991.7499.01
    Price to Book (x)4.886.303.963.193.42
    EV/EBITDA (x)29.2231.5622.8419.3423.48
    EBITDA Margin (%)19.8619.5119.3819.0018.69

Found Financials useful?

Share Price Forecast

Exclusively for ETPrime
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP
  • Stock Forecast Non Prime User

    Invest in the Best

    Check two-year estimates on Price, Revenue & Earnings

    READ FOR FREE ON APP

Technicals

Peer Comparison

Shareholding Pattern

  • CategoryNo. of SharesPercentage% Change QoQ
    Promoters9,58,65,51164.21 %0.43
    Pledge49,59,5395.17 %-0.34
    FII41,11,7032.76 %-0.45
    DII2,82,26,19118.91 %0.60
    MF2,28,61,66415.31 %0.23
    Others2,10,98,79814.12 %-0.58
  • CategoryMar 2026Dec 2025Sep 2025Jun 2025
    Promoters64.2163.7763.7862.46
    Pledge5.175.525.525.70
    FII2.763.223.592.16
    DII18.9118.3018.3613.21
    Mutual Funds15.3115.0814.639.43
    Others14.1214.7014.2622.16

Mutual Funds Ownership

MF Ownership as on 30 April 2026

Corporate Actions

  • General Meeting

    -

    Jun 08, 2026

    Board Meeting

    Audited Results

    May 04, 2026

    Rights

    Rights ratio: 1 share for every 17 held at a price of Rs 512.0

    Feb 17, 2026

  • Announced onMeeting on
    May 04, 2026May 19, 2026
    Audited Results
    Feb 09, 2026Feb 17, 2026
    Rights issue of Equity Shares
    Jan 27, 2026Feb 05, 2026
    Quarterly Results
    Nov 06, 2025Nov 12, 2025
    Quarterly Results
    Jul 07, 2025Aug 01, 2025
    Quarterly Results
  • No Data Available

  • No Data Available

  • No Data Available

  • Announced onEx-Date
    Feb 17, 2026Mar 02, 2026
    Rights ratio: 1 share for every 17 held at a price of Rs 512.0
  • Announced onMeeting on
    Jun 08, 2026Jul 10, 2026
    -
    Dec 22, 2025Jan 23, 2026
    -
    Sep 04, 2025Sep 25, 2025
    -
    Jul 14, 2025Aug 12, 2025
    -
    Mar 28, 2025Apr 29, 2025
    -

About Healthcare Global

Healthcare Global Enterprises Ltd., incorporated in the year 1998, is a Small Cap company (having a market cap of Rs 9,413.50 Crore) operating in Hospitals & Allied Services sector.

Show More

Industry

Hospital

Key Indices Listed On

BSE SmallCap, BSE Healthcare, BSE AllCap, Nifty Smallcap 500, Nifty Microcap 250

Address

HCG Tower,No.8, P Kalinga Rao Road,Bengaluru, Karnataka - 560027

Executive Leadership

BS

B S Ajai Kumar

Executive Chairman
MM

Manish Mattoo

Executive Director & CEO
AT

Akshay Tanna

Non Exe.Non Ind.Director
AA

Anjali Ajaikumar

Non Exe.Non Ind.Director
Show More

Auditors

B S R & Co. LLP

FAQs about Healthcare Global share

  • 1. What's the Healthcare Global share price today?
    Healthcare Global share price is Rs 630.50 as on 12 Jun, 2026, 03:53 PM IST. Healthcare Global share price is up by 0.18% based on previous share price of Rs 636. Healthcare Global share price trend:
    • Last 12 Months: Healthcare Global share price moved up 15.69%
    • Last 3 Years: Healthcare Global Share price moved up by 100.19%
  • 2. What's the market capitalization of Healthcare Global?
    Healthcare Global share has a market capitalization of Rs 9,413.50 Cr. Within Hospitals & Allied Services sector, it's market cap rank is 16.
  • 3. What is Healthcare Global's 52 week high / low?
    In last 52 weeks Healthcare Global share had a high price of Rs 788.39 and low price of Rs 513.30
  • 4. What is the PE & PB ratio of Healthcare Global?
    The PE ratio of Healthcare Global stands at 681.94, while the PB ratio is 6.66.
  • 5. What are the returns for Healthcare Global share?
    Return Performance of Healthcare Global Shares:
    • 1 Week: Healthcare Global share price moved down by 0.86%

Top Gainers

As on 04:06 PM | 12 Jun 2026
IFCI
84.57
14.09 (20.00%)
Authum Investment
530.15
70.20 (15.27%)
Tata Teleservices
46.44
4.29 (10.18%)
Ashok Leyland
152.45
13.87 (10.01%)
Netweb Technologies
4,587.40
396.00 (9.45%)

Top Losers

As on 03:58 PM | 12 Jun 2026
Nestle India
1,375.70
-46.80 (-3.29%)
Oil India Ltd
417.80
-11.56 (-2.70%)
ONGC
246.20
-6.41 (-2.54%)
Tech Mahindra
1,429.20
-35.90 (-2.46%)
OneSource Specialty
1,612.50
-38.91 (-2.36%)

DATA SOURCES: TickerPlant (for live BSE/NSE quotes service) and Dion Global Solutions Ltd. (for corporate data, historical price & volume, F&O data). Sensex & BSE Quotes and Nifty & NSE Quotes are real-time and licensed from BSE and NSE respectively. All timestamps are reflected in IST (Indian Standard Time).

DISCLAIMER: Any and all content on this website including tools/analysis is provided to you only for convenience and on an “as-is, as- available” basis without representation and warranties of any kind. The content and any output of such tools/analysis is for informational purposes only and should not be relied upon or construed as an investment advice or guarantee for any specific performance/returns advice or considered as recommendation for the purchase or sale of any security or investment. You are advised to exercise caution, discretion and independent judgment with regards to the same and seek advice from professionals and certified experts before taking any decisions.

By using this site, you agree to the Terms of Service and Privacy Policy.